You have 9 free searches left this month | for more free features.

Crohn's

Showing 1 - 25 of 2,738

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Early Bowel Resection for Terminal Ileal Crohn's Disease

Recruiting
  • Crohn Disease
    • Sheffield, United Kingdom
      Sheffield Teaching Hospitals NHS Foundation Trust
    Oct 30, 2023

    IBD, IBD, Crohn Disease Trial in Tel Aviv (photobiomodulation treatment in the infrared (IR) range.)

    Recruiting
    • IBD
    • +2 more
    • photobiomodulation treatment in the infrared (IR) range.
    • Tel Aviv, Israel
      Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
    Nov 19, 2023

    Crohn Disease Trial in New York (Kono-S anastomosis (KSa), Side-to-side anastomosis (SSa))

    Not yet recruiting
    • Crohn Disease
    • Kono-S anastomosis (KSa)
    • Side-to-side anastomosis (SSa)
    • New York, New York
      Weill Cornell Medical Center
    Nov 17, 2023

    Crohn's Disease Trial (MR Enterography (MRE))

    Not yet recruiting
    • Crohn's Disease
    • MR Enterography (MRE)
    • (no location specified)
    Nov 13, 2023

    Crohn Disease, Pediatric Crohns Disease Trial in Bron (Blood samples, Biopsies)

    Not yet recruiting
    • Crohn Disease
    • Pediatric Crohns Disease
    • Blood samples
    • Biopsies
    • Bron, France
      Service Hépatologie, Gastroentérologie et Nutrition pédiatrique,
    Apr 24, 2023

    Crohn Disease Trial in Beijing (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Beijing, China
      Beijing Children's Hospital, Capital Medical University
    Jun 13, 2023

    Fate in Fistulizing Crohn's Disease in a Pediatric Population

    Active, not recruiting
    • Crohn Disease
    • (no location specified)
    Feb 25, 2023

    Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

    Not yet recruiting
    • Crohn Disease
    • +4 more
    • TDM-based infliximab intravenous therapy
    • Standard infliximab intravenous therapy
    • (no location specified)
    Sep 26, 2023

    Crohn Disease Trial (RVT-3101)

    Not yet recruiting
    • Crohn Disease
    • (no location specified)
    Jun 9, 2023

    Crohn Disease Trial in Roma (multimodal ultrasound)

    Recruiting
    • Crohn Disease
    • multimodal ultrasound
    • Roma, Italy
      Fondazione Policlinico Gemelli IRCCS
    Sep 25, 2023

    Crohn Disease Trial in Besançon (Kono-S anastomosis, Conventional anastomosis for ileocolonicresection of Crohn's disease)

    Not yet recruiting
    • Crohn Disease
    • Kono-S anastomosis
    • Conventional anastomosis for ileocolonicresection of Crohn's disease
    • Besançon, France
      CHu de Besançon
    Jul 26, 2023

    Mesenteric Bacterial Translocation in Evolved Crohn's Disease

    Recruiting
    • Crohn Disease
      • Terrassa, Barcelona, Spain
        Hospital Universitari MútuaTerrassa
      May 26, 2023

      Insomnia, Crohn Disease Trial in Lebanon (Behavioral Treatment, Sleep Education Treatment)

      Not yet recruiting
      • Insomnia
      • Crohn Disease
      • Behavioral Treatment
      • Sleep Education Treatment
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Jul 13, 2023

      IBD, Crohn Disease, Crohn Colitis Trial in Boston (Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool, Standard

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • +7 more
      • Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool
      • Standard Crohn's Disease Education
      • Boston, Massachusetts
        Massachusetts General Hospital
      Oct 11, 2022

      Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission Trial (BK003, Placebo)

      Not yet recruiting
      • Irritable Bowel Syndrome-like Symptoms
      • Crohn Disease Remission
      • BK003
      • Placebo
      • (no location specified)
      Oct 23, 2023

      Exclusive Enteral Nutrition in Adult Active Crohn's Disease

      Completed
      • Crohn's Disease
      • exclusive enteral nutrition treatment group
      • (no location specified)
      Apr 14, 2023

      Crohn Disease Trial in Santiago de Compostela (MBF-018 oral capsules)

      Recruiting
      • Crohn Disease
      • MBF-018 oral capsules
      • Santiago de Compostela, Galicia, Spain
        Hospital Clínico Universitario de Santiago de Compostela
      Jul 7, 2023

      Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

      Not yet recruiting
      • Ulcerative Colitis
      • Crohn's Disease
      • Vedolizumab IV
      • Vedolizumab SC
      • (no location specified)
      Oct 17, 2023

      Ustekinumab in Treatment of Crohn's Disease

      Completed
      • Ustekinumab
      • +3 more
        • Wenzhou, Zhejiang, China
          SAHWenzhouMU
        May 18, 2023

        IL-23-Responsive Immune Cell Subsets in Post-Operative

        Recruiting
        • Crohn´s Disease
          • Amsterdam, Noord-Holland, Netherlands
            Amsterdam UMC
          Aug 16, 2023

          Crohn Disease in Remission Trial in Ann Arbor (Low Sulfur Diet, Usual Diet)

          Not yet recruiting
          • Crohn Disease in Remission
          • Low Sulfur Diet
          • Usual Diet
          • Ann Arbor, Michigan
            University of Michigan
          May 4, 2023

          Darvadstrocel for Crohn's Fistula in the Realworld

          Completed
          • Crohn's Fistula
          • Madrid, Spain
            Fundacion Jimenez Diaz
          Feb 21, 2023

          Ustekinumab Intensification in Crohn's Disease

          Not yet recruiting
          • Crohn Disease
          • (no location specified)
          Jan 29, 2023

          Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

          Not yet recruiting
          • Crohn Disease
          • Infliximab
          • (no location specified)
          Apr 3, 2023

          Ustekinumab Among Bio-naive Crohn's Disease in China

          Not yet recruiting
          • Crohn Disease
          • Hangzhou, Zhejiang, China
          • +2 more
          Oct 9, 2023